SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-006158
Filing Date
2018-08-02
Accepted
2018-08-02 08:01:23
Documents
52
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20180630x10q.htm 10-Q 940051
2 EX-31.1 zyne-20180630ex311552892.htm EX-31.1 13578
3 EX-31.2 zyne-20180630ex31241c994.htm EX-31.2 13367
4 EX-32.1 zyne-20180630ex321dff512.htm EX-32.1 6150
5 EX-32.2 zyne-20180630ex322ac2a9d.htm EX-32.2 6166
6 GRAPHIC zyne20180630x10q001.jpg GRAPHIC 105267
  Complete submission text file 0001558370-18-006158.txt   4002479

Data Files

Seq Description Document Type Size
7 EX-101.INS zyne-20180630.xml EX-101.INS 821000
8 EX-101.SCH zyne-20180630.xsd EX-101.SCH 26856
9 EX-101.CAL zyne-20180630_cal.xml EX-101.CAL 29898
10 EX-101.DEF zyne-20180630_def.xml EX-101.DEF 119638
11 EX-101.LAB zyne-20180630_lab.xml EX-101.LAB 249398
12 EX-101.PRE zyne-20180630_pre.xml EX-101.PRE 221225
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 18986726
SIC: 2834 Pharmaceutical Preparations